SIRIO(SZ:300791)2021-04-28 16:00Financial Performance - The company's revenue for Q1 2021 was CNY 507,560,431.75, representing a 41.60% increase compared to CNY 358,453,538.56 in the same period last year[8]. - Net profit attributable to shareholders for Q1 2021 was CNY 57,360,400.88, up 14.68% from CNY 50,016,593.84 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was CNY 52,543,436.24, reflecting a 44.33% increase from CNY 36,405,546.95 in the previous year[8]. - Basic and diluted earnings per share for Q1 2021 were both CNY 0.48, an increase of 14.29% from CNY 0.42 in the previous year[8]. - The company achieved operating revenue of CNY 507.56 million in Q1 2021, representing a year-on-year growth of 41.60%[25]. - The net profit attributable to shareholders was CNY 57.36 million, a year-on-year increase of 14.68%[25]. - Total operating revenue for the first quarter was CNY 507,560,431.75, an increase of 41.6% compared to CNY 358,453,538.56 in the same period last year[59]. - Net profit for the first quarter reached CNY 57,360,400.88, representing a 14.7% increase from CNY 50,016,593.84 in the previous year[64]. - Earnings per share (EPS) for the quarter was CNY 0.48, compared to CNY 0.42 in the same quarter last year[64]. Cash Flow and Liquidity - The net cash flow from operating activities decreased by 76.31%, amounting to CNY 19,502,319.27 compared to CNY 82,339,493.88 in the same period last year[8]. - The company reported a net cash flow from operating activities of CNY 19.50 million, down 76.31% compared to the previous year[24]. - The company's cash and cash equivalents decreased from RMB 216,703,845.28 at the end of 2020 to RMB 183,710,606.52 by March 31, 2021[47]. - The company's cash flow from investment activities showed a significant decline, with a net outflow of CNY 46.42 million due to increased investments in fixed and intangible assets[24]. - Cash and cash equivalents at the end of the period decreased to ¥178,231,542.37, down from ¥484,598,603.55 in the previous period[74]. - The total cash outflow from investing activities was ¥174,680,515.82, compared to ¥1,276,136,480.91 in the previous period, indicating a significant reduction[72]. - The net cash flow from operating activities decreased to ¥24,367,178.91 from ¥81,940,136.08, representing a decline of approximately 70.3% year-over-year[75]. - The total cash and cash equivalents at the end of the period stood at ¥89,279,327.08, a decrease from ¥399,694,079.03, reflecting a drop of approximately 77.7%[77]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,738,312,278.19, a 3.35% increase from CNY 2,649,636,693.93 at the end of the previous year[8]. - Total liabilities amounted to CNY 495,910,579.00, up from CNY 466,949,418.29, which is an increase of around 6.67%[51]. - Current liabilities rose to CNY 415,845,954.15, compared to CNY 387,058,047.42, indicating an increase of approximately 7.25%[51]. - Owner's equity reached CNY 2,242,401,699.19, compared to CNY 2,182,687,275.64, showing a growth of about 2.74%[53]. - Total assets increased to CNY 2,738,312,278.19, up from CNY 2,649,636,693.93, representing a growth of approximately 3.33%[49]. - Non-current assets totaled CNY 1,412,055,581.79, an increase from CNY 1,325,804,646.00, reflecting a growth of about 6.49%[49]. - The total liabilities of the company were CNY 240,156,626.59, an increase from CNY 234,775,859.46 in the previous period[61]. - Total equity increased to CNY 2,176,146,777.57 from CNY 2,134,896,033.78 year-over-year[61]. Research and Development - The company's R&D expenses increased by 59.43% to CNY 17.54 million, reflecting a commitment to innovation[21]. - Research and development expenses for the quarter were CNY 17,541,154.80, up from CNY 11,002,501.64 in the same period last year, indicating a focus on innovation[61]. - The company incurred research and development expenses of ¥13,234,613.99, which is an increase of 37.5% from ¥9,623,227.56 in the previous period[67]. Market and Competition - The company is facing intensified market competition, with a rapid increase in the number of players in the nutritional health food sector over the past decade[32]. - The company is actively pursuing new product development and market expansion strategies to sustain its competitive edge in the industry[32]. - The company has implemented an integrated product development system (IPD) to enhance coordination among sales, marketing, and R&D functions, aiming to strengthen its market position[33]. Regulatory and Compliance - The company has established a professional regulatory department to monitor and adapt to changes in industry regulations, ensuring compliance and minimizing operational risks[31]. - The company has not undergone an audit for the first quarter report, which may affect the perception of financial reliability[85]. - The company has implemented new leasing standards, which have resulted in adjustments to its financial statements[84]. Government Support - The company received government subsidies amounting to CNY 4,175,224.20 during the reporting period[8]. - The company received government subsidies of CNY 4.18 million during the period, down from CNY 15.62 million in the same period last year[25]. Inventory and Costs - Inventory rose by 30.33% to CNY 347.68 million, driven by increased business volume[20]. - The gross profit margin for the period was impacted by increased operating costs, with operating costs rising by 39.54% to CNY 327.54 million[21]. - Total operating costs amounted to CNY 444,345,727.83, up 41.2% from CNY 314,499,746.72 year-over-year[61].